Stanford-onderzoekers presenteren AI-agenten die medicijnonderzoek kunnen transformeren

Stanford researchers will present autonomous AI systems designed to accelerate pharmaceutical development by automating complex research workflows that traditionally require years of human collaboration. These AI agents aim to address drug discovery's notoriously low success rate and reduce the substantial time and financial investment required to bring new medications to market.